|
Name |
Aliarin
|
Molecular Formula | C22H24O8 | |
IUPAC Name* |
5,7-dihydroxy-2-[4-hydroxy-3-(4-hydroxy-3-methylbutyl)phenyl]-3,6-dimethoxychromen-4-one
|
|
SMILES |
CC(CCC1=C(C=CC(=C1)C2=C(C(=O)C3=C(O2)C=C(C(=C3O)OC)O)OC)O)CO
|
|
InChI |
InChI=1S/C22H24O8/c1-11(10-23)4-5-12-8-13(6-7-14(12)24)20-22(29-3)19(27)17-16(30-20)9-15(25)21(28-2)18(17)26/h6-9,11,23-26H,4-5,10H2,1-3H3
|
|
InChIKey |
VLVYYPSDJMDDBM-UHFFFAOYSA-N
|
|
Synonyms |
Aliarin; 84294-77-9; 5,7-DIHYDROXY-2-[4-HYDROXY-3-(4-HYDROXY-3-METHYLBUTYL)PHENYL]-3,6-DIMETHOXYCHROMEN-4-ONE; CHEBI:185664; J3.644.852K; 3,6-Dimethoxy-3'-[3-(hydroxymethyl)butyl]-4',5,7-trihydroxyflavone
|
|
CAS | NA | |
PubChem CID | 91886680 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 416.4 | ALogp: | 3.5 |
HBD: | 4 | HBA: | 8 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 126.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.456 |
Caco-2 Permeability: | -4.921 | MDCK Permeability: | 0.00000873 |
Pgp-inhibitor: | 0.926 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.033 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 96.74% |
Volume Distribution (VD): | 0.546 | Fu: | 5.13% |
CYP1A2-inhibitor: | 0.868 | CYP1A2-substrate: | 0.893 |
CYP2C19-inhibitor: | 0.316 | CYP2C19-substrate: | 0.066 |
CYP2C9-inhibitor: | 0.779 | CYP2C9-substrate: | 0.764 |
CYP2D6-inhibitor: | 0.58 | CYP2D6-substrate: | 0.331 |
CYP3A4-inhibitor: | 0.329 | CYP3A4-substrate: | 0.141 |
Clearance (CL): | 4.532 | Half-life (T1/2): | 0.808 |
hERG Blockers: | 0.049 | Human Hepatotoxicity (H-HT): | 0.079 |
Drug-inuced Liver Injury (DILI): | 0.966 | AMES Toxicity: | 0.523 |
Rat Oral Acute Toxicity: | 0.11 | Maximum Recommended Daily Dose: | 0.097 |
Skin Sensitization: | 0.706 | Carcinogencity: | 0.033 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.762 |
Respiratory Toxicity: | 0.061 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001751 | 0.526 | D06GCK | 0.466 | ||||
ENC002626 | 0.520 | D0K8KX | 0.420 | ||||
ENC001573 | 0.444 | D04AIT | 0.346 | ||||
ENC001772 | 0.438 | D0G4KG | 0.298 | ||||
ENC001571 | 0.430 | D07MGA | 0.277 | ||||
ENC005522 | 0.425 | D0U3YB | 0.268 | ||||
ENC001529 | 0.420 | D0AZ8C | 0.268 | ||||
ENC002471 | 0.414 | D0QD1G | 0.267 | ||||
ENC002475 | 0.396 | D02LZB | 0.256 | ||||
ENC001405 | 0.394 | D0Y7TS | 0.256 |